// you’re reading...

General Biotechnology

5 Big Drug Companies Face R&D Drought

By Yali ⋅ June 19, 2002 ⋅ Email This Post Email This Post ⋅ Print This Post Print This Post ⋅ Post a comment

5 Big Drug Companies Face R&D Drought
Five of the world’s biggest drug companies do not have any potential billion-dollar drugs in late-stage development, highlighting the industry’s current poor R&D productivity, according to a report released on Wednesday.

Print This Post

Discussion

No comments for “5 Big Drug Companies Face R&D Drought”

Post a comment

Building Biotechnology - Starting, Managing, and Understanding Biotechnology Companies   The Business of Biotechnology - Profit From the Growing Influence of Biotechnology
Best Practices in Biotechnology Business Development Best Practices in Biotechnology Education
Journal of Commercial Biotechnology 
DrugPatentWatch.com